Small Cap Voice

Dr. Bill Williams, President and CEO BriaCell Therapeutics Corp. ("BriaCell") (BCT.V) (BCTXF), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology, called in to SmallCapVoice.com, Inc. to discuss some of the recent news and highlights for the company. Recently the Company announced that Sylvester Comprehensive Cancer Center at the University of Miami is now actively screening and enrolling patients in the ongoing, multicenter, Phase IIa study of Bria-IMT™ in advanced breast cancer. Another validation of the Company's work came through its presentations at the 2018 American Association of Cancer Research (AACR) Annual Meeting.

This interview may include forward looking statements. These forward-looking statements generally are identified by the words "believe," "project," "estimate," "become," "plan," "will," and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. SmallCapVoice.com, Inc. received 2,500 from the company on 4-2-18 for 30 days of service.

Dr. William Williams, BriaCell’s President & CEO, called in to SmallCapVoice.com, Inc. to discuss BriaCell Therapeutics Corp.’s history, management, advisory board, Bria-IMT™ (SV-BR-1-GM), the Company's lead product candidate as a targeted and safe approach to the management of cancer, and more. Recently, the Company announced the acceptance of a manuscript describing the novel mechanism of action of the Company’s lead product candidate, Bria-IMT™. The findings detailed in the paper provide a rationale for the encouraging clinical results observed with Bria-IMT™ in current and past clinical testing. The publication will appear in Frontiers in Immunology, the 5th most cited journal in Immunology worldwide. Bria-IMT™, also known as SV-BR-1-GM, has caused remarkable reduction of tumor size in some patients with advanced metastatic breast cancer.

BriaCell is an immuno-oncology focused biotechnology company developing a targeted and safe approach to the management of cancer. Immunotherapy has come to the forefront in the fight against cancer, harnessing the body's own immune system in recognizing and selectively destroying cancer cells while sparing normal ones. Immunotherapy, in addition to generally being more targeted and less toxic than commonly used types of chemotherapy, is also thought to be a potent approach with the potential to prevent cancer recurrence.

Bria-IMT™ (SV-BR-1-GM), the Company's lead product candidate, is derived from a specific breast cancer cell line. It is genetically engineered to release granulocyte-macrophage colony-stimulating factor (GM-CSF), a substance that activates the immune system. We believe that Bria-IMT™ helps the body to recognize and kill tumor cells by activating T cells that attack the tumor and B cells that produce anti-tumor antibodies.

The results of two previous proof-of-concept clinical trials (one with the precursor cell line not genetically engineered to produce GM-CSF and one with Bria-IMT™) produced encouraging results in patients with advanced breast cancer. Most notably, one patient with metastatic breast cancer responded to Bria-IMT™ with substantial reduction in tumor burden including breast, lung, soft tissue and brain metastases. BriaCell is currently conducting a Phase I/IIa clinical trial for Bria-IMT™ in patients with advanced breast cancer. In this trial, Bria-IMT™ treatment appeared safe with similar instances of tumor reduction as those observed in the earlier proof-of-concept trials. This trial is listed in ClinicalTrials.gov as NCT03066947. The trial is being conducted along with the co-development of BriaDX™, the Company’s companion diagnostic test. Additionally, the FDA recently approved the roll-over combination study of Bria-IMT™ with pembrolizumab [Keytruda; manufactured by Merck & Co., Inc.] or ipilimumab [Yervoy; manufactured by Bristol-Myers Squibb Company] for patients previously treated with Bria-IMT™ in the Company’s ongoing Phase I/IIa clinical trial in advanced breast cancer. The roll-over trial is listed in ClinicalTrials.gov as NCT03328026.

BriaCell is also developing Bria-OTS™, an off-the-shelf personalized Immunotherapy. Bria-OTS™ is a set of cell lines similar to Bria-IMT™ which are being engineered to express pre-manufactured HLA alleles. With a combined total of 15 different alleles Bria-OTS™ is expected to be able to match more than 90% of the US population. BriaCell’s BriaDX™ companion diagnostic reveals patient HLA types. One or two Bria-OTS™ cell lines carrying matching alleles are planned to be administered per patient. Bria-OTS™ eliminates the complex manufacturing logistics required for other personalized immunotherapies and is regarded as a personalized therapy without the need for personalized manufacturing.

Yet another item in the BriaCell pipeline is a novel, selective protein kinase C delta (PKCδ) inhibitor. PKCδ inhibitors have shown activity in a number of pre-clinical models of RAS genes’ transformed cancers including breast, pancreatic, non-small cell lung cancer and neuroendocrine tumors (such as carcinoid tumors).

For additional information on BriaCell, please visit our website: http://briacell.com.

This interview may include forward looking statements. These forward-looking statements generally are identified by the words "believe," "project," "estimate," "become," "plan," "will," and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. On 1-11-18 SmallCapVoice.com, Inc. signed a 90 day agreement for $2,500 per month and 52,500 restricted shares subject to Rule 144 of the Securities Act of 1933 for the 90 day term.

Daniel Crawford CEO of Right On Brands, Inc.™ (OTC QB: RTON) called back in to SmallCapVoice.com, Inc. to discuss the recent news and the Company’s recent stint as an exhibitor at the 37th annual Natural Products Expo West. Right On Brands, Inc. ™, a Santa Monica California based consumer goods company specializing in the brand development of health conscious, hemp-infused food and beverage products. The company consists of three subsidiaries Humbly Hemp™, Endo Brands™ and Humble Water Company™.

Humbly Hemp™ is a product line of delicious hemp-based plant protein products. The snack line features hemp-based foods that will delight the palette of consumers and thrill retailers with America’s fastest growing food category. (Available on Amazon.com, and humblyhemp.com)

Humbly Hemp™ snack bars are straightforward, delicious, and jam-packed with the best ingredients on earth. Each bar is kosher, vegan, soy free, dairy free, gluten-free, and free of all top 11 allergens. Our protein bars feature a base of Gluten Free Rolled Oats, Hemp seeds, and Plant Protein. We offer three flavors: Cinnamon Date, Berry Vanilla, and Cocoa + Sea Salt.

Order Humbly Hemp at: https://www.humblyhemp.com/

Endo Brands™ Cannabinoid products are a wholesome addition to increase overall wellness in your life. We infuse our ENDO Hemp CBD oil in supplements, drinks, and your favorite snacks.

Endo Water™ pH balanced, micro-clustered for antioxidant protection and oxygenated for improved performance and energy.

Available in four flavors: Berry Acai, Lemon Lime, Cucumber, Watermelon, with a PURE unflavored version coming out in April.

Endo Drops are alcohol-free coconut oil based tinctures that you take orally by mouth.

Available in three flavors: Berry, Ginger Citrus, and Mint.

Order Endo Brands products at https://www.endobrands.com/

Visit our corporate website at https://RightOnBrands.com

This interview may include forward looking statements. These forward-looking statements generally are identified by the words "believe," "project," "estimate," "become," "plan," "will," and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. On 1-11-18 SmallCapVoice.com, Inc. signed a 90 day agreement for $2,500 per month and 52,500 restricted shares subject to Rule 144 of the Securities Act of 1933 for the 90 day term.

Mark Miller called in to SmallCapVoice.com, Inc. to discuss the business model, his history in the construction and real estate markets, the current markets served and the goals for 2018. Recently, MEDH announced that they have successfully completed the acquisition of MJ Builders LLC as a Wholly Owned subsidiary valued at $1,000,000. MedX Holdings, Inc. is a publicly trading holding company with businesses and assets in the custom housing, construction, and real estate market sector.

This interview may include forward looking statements. These forward-looking statements generally are identified by the words "believe," "project," "estimate," "become," "plan," "will," and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. SmallCapVoice.com, Inc. received $2,500 from from a third party on behalf of the issuer on 3-14-18 for 30 days of service.

NEWPORT BEACH, CA--(Marketwired - March 15, 2018) - Terra Tech Corp. (OTCQX: TRTC) (OTCQX: TRTCD) ("Terra Tech") or (the "Company"), a vertically integrated cannabis-focused agriculture company, today announced that it will release its full-year 2017 results on Friday, March 16, 2018 after U.S. markets close.

The company will also host a conference call on Friday, March 16, 2018 at 4:30 PM Eastern Time.

Dial-In Number: 1-857-232-0157

Access Code: 422095

Derek Peterson, Chairman and CEO of Terra Tech Corp., will be answering shareholder questions at the end of the call. Should you have questions during or prior to the conference call please send an email to [email protected] with 'TRTC Question' in the subject line. Mr. Peterson will answer as many questions as time will allow.

For those unable to participate in the live conference call, a replay will be available at https://www.smallcapvoice.com/trtc/. An archived version of the webcast will also be available on the investor relations section of the company's website.

To be added to the Terra Tech email distribution list, please email [email protected] with TRTC in the subject line.

About Terra Tech

Terra Tech Corp. (OTCQX: TRTC) operates through multiple subsidiary businesses including: Blüm, IVXX Inc., Edible Garden, and MediFarm LLC. Blüm's retail and medical cannabis facilities provide the highest quality medical cannabis to patients who are looking for alternative treatments for their chronic medical conditions as well as premium cannabis to the adult-use market in Nevada and California. Blüm offers a broad selection of cannabis products including; flowers, concentrates and edibles through its Oakland, CA and multiple Nevada locations. IVXX, Inc. is a wholly-owned subsidiary of Terra Tech that produces cannabis-extracted products for regulated medical cannabis dispensaries throughout California and medical and adult-use dispensaries in Nevada. The Company's wholly-owned subsidiary, Edible Garden, cultivates a premier brand of local and sustainably grown hydroponic produce, sold through major grocery stores such as ShopRite, Walmart, Ahold, Aldi, Meijer, Kroger, Stop & Shop and others nationwide. Terra Tech's MediFarm LLC subsidiaries are focused on medical and adult-use cannabis cultivation and permitting businesses throughout Nevada.

For more information about Terra Tech Corp visit: http://www.terratechcorp.com/ 

For more information about IVXX visit: http://ivxx.com/ 

For more information about Blüm Nevada visit: http://letsblum.com

For more information about Blüm Oakland visit: http://blumoak.com/ 

Visit us on Facebook @ https://www.facebook.com/terratechcorp/timeline 

Follow us on Twitter @terratechcorp 

For more information about Edible Garden visit: http://www.ediblegarden.com/ 

Visit Edible Garden on Facebook @ https://www.facebook.com/ediblefarms?fref=ts 

Visit IVXX on Facebook @ https://www.facebook.com/ivxxbrand?fref=ts

Cautionary Language Concerning Forward-Looking Statements

Statements in this press release may be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "anticipate", "believe", "estimate", "expect", "intend" and similar expressions, as they relate to the company or its management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the company's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including those described above and those risks discussed from time to time in Terra Tech Corp.'s filings with the Securities and Exchange Commission. In addition, such statements could be affected by risks and uncertainties related to Terra Tech Corp.'s (i) product demand, market and customer acceptance of its equipment and other goods, (ii) ability to obtain financing to expand its operations, (iii) ability to attract qualified sales representatives, (iv) competition, pricing and development difficulties, (v) ability to integrate GrowOp Technology Ltd. into its operations as a reporting issuer with the Securities and Exchange Commission, and (vi) general industry and market conditions and growth rates and general economic conditions. Any forward-looking statements speak only as of the date on which they are made, and the company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this release. Information on Terra Tech Corp.'s website does not constitute a part of this release.

Contact

Philip Carlson 

Elizabeth Barker

KCSA Strategic Communications

212-896-1238

Natalia A Lopera, CEO, and Frank Gillen, Administrator, of Hip Cuisine, Inc. (Pink Sheets: HIPC) called in to SmallCapVoice.com, Inc. to go over the business model, history, markets served and much more in their first interview. Recently, the company announced that it has retained Newbridge Securities Corporation (“Newbridge”), a full-service securities brokerage and investment banking firm, to provide strategic corporate finance and investment banking services.

Hip Cuisine is a global nutritional foods company, that brings fresh, organic foods to the health-conscious consumer. The Company has two retail food locations in Panama City, through its subsidiary, Hip Cuisine Panama, as well as another 3 locations in Southern California through its subsidiary, RAWkin’ Juice. RAWkin’ Juice is a popular maker of organic-vegan juices and smoothies, salads, and desserts. Hip Cuisine also owns Living Gourmet, a line of fresh, organic raw-vegan foods, which include vegan burgers, sandwiches, burritos and soups. The Company also has various joint-ventures with select specialty food, beverage and lifestyle health brands, including an exclusive distribution agreement with Medidate Coffee, a gourmet antioxidant and protein-rich coffee made from date seeds, and a retailer agreement with Charlotte’s Web, a maker of high-cannabidiol (CBD), low-tetrahydrocannabinol (THC) Cannabis extract marketed as a dietary supplement.

The Company’s corporate headquarters are located at 2250 NW 114th Ave. Unit 1P, PTY 11020, Miami, FL 33172, and has additional corporate offices in Balboa Boutiques, Ave. Balboa, Local 104, Panama City, Panama. Email questions to [email protected]

For more information on our various brands and partners:

Hip Cuisine http://www.hip-cuisine.com

RAWkin’ Juice http://www.rawkinjuice.com

Medidate Coffee http://www.medidatecoffee.com

Charlotte’s Webb http://www.cwhemp.com

This interview may include forward looking statements. These forward-looking statements generally are identified by the words "believe," "project," "estimate," "become," "plan," "will," and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof.

Mr. Fernando Oswaldo Leonzo, Chairman and Chief Executive Officer of Life On Earth, Inc. (OTC QB: LFER), called in to SmallCapVoice.com, Inc. to discuss the recent name and symbol change, the fundamental differences between the current company and its predecessor, the current markets served and the goals for 2018. In a recent letter to the shareholders the company outlined its recent moves, brand development: Victoria’s Kitchen, Gran Nevada, and Life On Earth Tea brands, and the shifting focus to distribution of its brand.

Life on Earth, Inc. (LFER) a “Naturally Better Way” consumer based Brand Accelerator Company is a dynamic and innovative all-natural consumables products company focused but not limited to the beverage and snack industry. At LFER, we have established a unique business model focused on building brands within the alternative beverage and snack space. Our brand model is complimented by our strong distribution subsidiaries. Energy Source Distributors, Inc. (“ESD”) in California and The Giant Beverage Company, Inc. in New York (“Giant”). The growth of “game changing” marketing applications, human capital resources and follow-on investments will help us deliver more fully integrated brand offerings that are good for our consumers and the environment.

This interview may include forward looking statements. These forward-looking statements generally are identified by the words "believe," "project," "estimate," "become," "plan," "will," and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. SmallCapVoice.com, Inc. received $2,500 from a third party on behalf of the issuer on 2-26-18 for 30 days of service.

TARRYTOWN, N.Y., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Innovative snack brand development company NightFood Holdings, Inc. (OTC: NGTF), is pleased to announce that the Company has scheduled an investor conference call at 4:30 PM eastern standard time on Thursday, Mar 1st, 2018.

"It’s been a very eventful and very successful three months for both NightFood and MJ Munchies,” commented Company CEO Sean Folkson. “We respect the importance of open communication, and enjoy keeping investors up to date on Company developments through these ongoing quarterly calls.”

On the call, NightFood Founder and CEO, Sean Folkson, will address:

The MJ Munchies and Half-Baked™ initiatives, including the Company acquisition of HalfBaked.com

NightFood’s addition of Greg Getner as head of digital growth, and Dr. Michael Breus, The Sleep Doctor™, to the NightFood brand team

The product development pipeline for both MJ Munchies and NightFood

In addition, interested parties have the opportunity to submit questions concerning the Company prior to the call to Stuart Smith at SmallCapVoice.Com, Inc. via email: [email protected] by 12:00 PM eastern standard time on Monday, February 26, 2018. Mr. Smith will compile a list of questions and submit them to the Company prior to the conference call. Which questions will be addressed will be based on the relevance to the shareholder base, and the question’s appropriateness in light of public disclosure rules.

To access the call:

Dial-In Number: 1-857-232-0157

Access Code: 422095

For those unable to participate in the live conference call, a replay will be available at https://www.smallcapvoice.com/ngtf/ shortly after the call has concluded. An archived version of the webcast will also be available http://ir.nightfood.com

About NightFood:

NightFood (OTC: NGTF), operates both NightFood, Inc. and MJ Munchies, Inc.

NightFood, Inc, “The Nighttime Snack Company”, is a snack food company dedicated to providing consumers delicious, better-for-you, sleep-friendly choices for evening snacking and nighttime cravings. According to IRI Worldwide, 44% of snack consumption occurs at night, representing a consumer spend of over $1B weekly on nighttime snacks.

Market research giant Mintel recently released a report identifying nighttime specific food and beverages as one of their most “compelling and category changing” trends for 2017 and beyond.

Currently, consumers’ most popular choices are cookies, chips, ice cream, and candy. These options are generally understood to be unhealthy, and often contain ingredients and nutritional profiles that can impair sleep quality. NightFood creates, manufactures, and distributes snacks formulated to help consumers satisfy nighttime cravings in a better, healthier, more sleep friendly way.

MJ Munchies, Inc. was recently formed as a new, wholly owned subsidiary, to exploit legally compliant opportunities in the CBD and marijuana edibles and related spaces. The Company intends to market some of these new products under the brand name “Half-Baked”. MJ Munchies recently acquired the valuable domain name, HalfBaked.com. As the legal landscape around CBD and cannabis related products continues to change and evolve, MJ Munchies will continue to explore, identify, and capitalize on opportunities clearly defined as legal. The Company believes tremendous opportunities currently exist to launch successful and compliant products in this space, and that such opportunities will continue to grow over time.

For more information, visit http://ir.nightfood.com and www.nightfood.com

Questions can be directed to [email protected]

Forward Looking Statements:

This current press release contains "forward-looking statements," as that term is defined in Section 27A of the United States Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future, including but not limited to, any products sold or cash flow from operations.

Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with distribution and difficulties associated with obtaining financing on acceptable terms. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our most recent annual report for our last fiscal year, our quarterly reports, and other periodic reports filed from time-to-time with the Securities and Exchange Commission.

Media Contact:

Peter Leighton

888-888-6444, x5

Investor Contact:

Parker Mitchell

Regal Consulting, LLC

SmallCapVoice.com, Inc. received $875 from the company on 3-1-18 for 30 days of audio interview service.

S. Parikh Mars, CEO of Progressive Care Inc. (OTCQB: RXMD), called in to SmallCapVoice.com, Inc. to discuss the recent news and achievements for the Company. So far in 2018, Progressive Care has announced 23,000 prescriptions during the month of January, generating $1.8 million in net revenues. That is record for the Company and up 34% from the same month in 2017. RXMD is also proud of the work they are accomplishing with Mass Ventures Corp, a Florida company, who has significantly enhanced the digital presence and technology solutions for the company and all subsidiaries. Other important achievements include the expansion into Palm Beach County and the news that its retail pharmacy will officially begin accepting Bitcoin payments.

Progressive Care Inc., through its subsidiaries Smart Medical Alliance, Inc. and PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, administration and practice management, utilization management, quality assurance, EHR Implementation, billing and coding, and health practice risk management.

This interview may include forward looking statements. These forward-looking statements generally are identified by the words "believe," "project," "estimate," "become," "plan," "will," and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. SmallCapVoice.com, Inc. received $2,500 from the company on 12-14-17 for 30 days of service.

Todd Davis, CEO of Endexx (OTC PINK: EDXC), a provider of innovative phytonutrient-based food and nutritional products, called in to SmallCapVoice.com, Inc. to discuss the recently released financial results for the Company, contract with Impulse Health to bring retail products into its AutoSpense Technology dispensing solutions, the goals for 2018 and more.

Endexx, with its collaborative partners and consultants, develops and distributes two consumable product lines derived from industrial hemp, which is organic and naturally rich in phytocannabinoids. Phyto-Bites, is its CBD-infused soft chews for dogs. The dog treats are formulated to promote health and support the reduction of separation anxiety, pain and inflammation. The company also has two technology products and services that launched in 2014 -- the M3hub and the Autospense. Both products provide essential solutions to promote regulatory compliance and full accountability through "seed to sale" inventory management and, an "End of Sale" technology integration. Based on principles developed by the pharmacological industry, the m3hub platform is the first standardized software solution for tracking pharmaceutical grade marijuana that maintains compliance with federal, state and local regulations. It is intended to provide a smooth transition to eventual federal mandates. The Autospense is a commercial grade inventory control and dispensing device that provides up-to-the-minute accounting details and ensures both product and patient security. By automating the dispensing process, Autospense increases productivity and reduces costs for marijuana retailers, while enhancing their service quality by reducing transaction time for customers.

Websites include: www.cbdunlimited.com, www.endexx.com, www.phytobites.com, www.m3hub.com, www.holisticearthremedies.com.

This interview may include forward looking statements. These forward-looking statements generally are identified by the words "believe," "project," "estimate," "become," "plan," "will," and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. SmallCapVoice.com, Inc. received $1,500 from the company on 2-12-18 for 30 days of service.